Stress-Induced Hypercoagulability: Insights from Epidemiological and Mechanistic Studies, and Clinical Integration

Abstract

By integrating findings from comprehensive reviews, meta-analyses, and cutting-edge genetic studies, this article illuminates the significance of stress-induced hypercoagulability in clinical medicine. In particular, the findings from numerous prospective cohort studies indicate that stress and hemostatic factors of a hypercoagulable state are associated with increased incident risk and poor prognosis for atherosclerotic cardiovascular disease and venous thromboembolism. Mendelian randomization studies suggest that these associations are partially causal. The review synthesizes extensive research on the link between acute and chronic stress and hypercoagulability, outlining a potential pathway from stress to thrombosis risk. Consistent with the allostatic load concept, acute stress-induced hypercoagulability, initially adaptive, can turn maladaptive under chronic stress or excessive acute stress, leading to arterial or venous thrombotic events. Individuals with predisposing factors, including atherosclerosis, thrombophilia, or immobilization, may exhibit an increased risk of thrombotic disease during stress. Contextual sociodemographic characteristics, the stress experience, and coping resources additionally modulate the extent of stress-induced hypercoagulability. Research into the neuroendocrine, cellular, and molecular bases reveals how stress influences platelet activation coagulation and fibrinolysis. The activation of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis, along with vagal withdrawal, and the effects of catecholamines, cortisol, and vasopressin, are the central mechanisms involved. Hemoconcentration, inflammation, endothelial dysfunction, and thrombopoiesis additionally contribute to stress-induced hypercoagulability. Further research is needed to prove a causal link between chronic stress and hypercoagulability. This includes exploring its implications for the prevention and management of thrombotic diseases in stressed individuals, with a focus on developing effective psychosocial and pharmacological interventions.

Keywords

blood coagulation - fibrinolysis - platelets - psychological stress - mental disorder

Publication History

Article published online:
24 June 2024

• References

• 1 Camacho A, Dimsdale JE. Platelets and psychiatry: lessons learned from old and new studies. Psychosom Med 2000; 62 (03) 326-336
• 2 von Känel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease?. Psychosom Med 2001; 63 (04) 531-544
• 3 Thrall G, Lane D, Carroll D, Lip GY. A systematic review of the prothrombotic effects of an acute change in posture: a possible mechanism underlying the morning excess in cardiovascular events?. Chest 2007; 132 (04) 1337-1347
• 4 Austin AW, Wissmann T, von Kanel R. Stress and hemostasis: an update. Semin Thromb Hemost 2013; 39 (08) 902-912
• 5 von Känel R. Acute mental stress and hemostasis: when physiology becomes vascular harm. Thromb Res 2015; 135 (Suppl. 01) S52-S55
• 6 Bentur OS, Sarig G, Brenner B, Jacob G. Effects of acute stress on thrombosis. Semin Thromb Hemost 2018; 44 (07) 662-668
• 7 Sandrini L, Ieraci A, Amadio P, Zarà M, Barbieri SS. Impact of acute and chronic stress on thrombosis in healthy individuals and cardiovascular disease patients. Int J Mol Sci 2020; 21 (21) 7818
• 8 Izzi B, Tirozzi A, Cerletti C. et al. Beyond haemostasis and thrombosis: platelets in depression and its co-morbidities. Int J Mol Sci 2020; 21 (22) 8817
• 9 Mennesson M, Revest JM. Glucocorticoid-responsive tissue plasminogen activator (tPA) and its inhibitor plasminogen activator inhibitor-1 (PAI-1): relevance in stress-related psychiatric disorders. Int J Mol Sci 2023; 24 (05) 4496
• 10 Stassen JM, Arnout J, Deckmyn H. The hemostatic system. Curr Med Chem 2004; 11 (17) 2245-2260
• 11 Kivimäki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol 2018; 15 (04) 215-229
• 12 Pogosova N, Saner H, Pedersen SS. et al; Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Psychosocial aspects in cardiac rehabilitation: from theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 2015; 22 (10) 1290-1306
• 13 Hoffman M, Monroe III DM. A cell-based model of hemostasis. Thromb Haemost 2001; 85 (06) 958-965
• 14 Dati F, Pelzer H, Wagner C. Review. Laboratory tests for markers of activation of coagulation and fibrinolysis. J Lab Med 1997; 21 (06) 314-324
• 15 Greaves M. Assessment of haemostasis. Vox Sang 2004; 87 (Suppl1): 47-50
• 16 Cannon WB, Mendenhall WL. Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement. Am J Physiol 1914; 34: 251-261
• 17 Floriou-Servou A, von Ziegler L, Waag R, Schläppi C, Germain PL, Bohacek J. The acute stress response in the multiomic era. Biol Psychiatry 2021; 89 (12) 1116-1126
• 18 McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338 (03) 171-179
• 19 Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016; 118 (09) 1340-1347
• 20 Obara H, Matsubara K, Kitagawa Y. Acute limb ischemia. Ann Vasc Dis 2018; 11 (04) 443-448
• 21 Niculae CM, Hristea A, Moroti R. Mechanisms of COVID-19 associated pulmonary thrombosis: a narrative review. Biomedicines 2023; 11 (03) 929
• 22 Lowe G. Can haemostatic factors predict atherothrombosis?. Intern Emerg Med 2011; 6 (06) 497-501
• 23 Zhao W, Lee JJ, Rasheed A, Saleheen D. Using Mendelian randomization studies to assess causality and identify new therapeutic targets in cardiovascular medicine. Curr Genet Med Rep 2016; 4 (04) 207-212
• 24 Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R. ISTH SSC Subcommittee on Women's Health Issues. Preanalytical conditions that affect coagulation testing, including hormonal status and therapy. J Thromb Haemost 2007; 5 (04) 855-858
• 25 Schreijer AJ, Cannegieter SC, Doggen CJ, Rosendaal FR. The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol 2009; 144 (03) 425-429
• 26 Lippi G, Franchini M, Favaloro EJ. Holiday thrombosis. Semin Thromb Hemost 2011; 37 (08) 869-874
• 27 Lindqvist PG, von Känel R. How to avoid venous thromboembolism in women at increased risk–with special focus on low-risk periods. Thromb Res 2015; 136 (03) 513-518
• 28 Mostofsky E, Penner EA, Mittleman MA. Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysis. Eur Heart J 2014; 35 (21) 1404-1410
• 29 Connell J, Oldham M, Pandharipande P. et al. Malignant catatonia: a review for the intensivist. J Intensive Care Med 2023; 38 (02) 137-150
• 30 Baltzer Nielsen S, Stanislaus S, Saunamäki K, Grøndahl C, Banner J, Jørgensen MB. Can acute stress be fatal? A systematic cross-disciplinary review. Stress 2019; 22 (03) 286-294
• 31 Haouzir S, Lemoine X, Desbordes M. et al. The role of coagulation marker fibrin D-dimer in early diagnosis of catatonia. Psychiatry Res 2009; 168 (01) 78-85
• 32 Ishida T, Shibahashi K, Sugai S. et al. Development of a risk stratification scoring system for deep vein thrombosis upon psychiatric admission. J Psychosom Res 2021; 147: 110540
• 33 Hussar AE. Leading causes of death in institutionalized chronic schizophrenic patients: a study of 1,275 autopsy protocols. J Nerv Ment Dis 1966; 142 (01) 45-57
• 34 Arnone D, Hansen L, Davies G. Pulmonary embolism and severe depression. Am J Psychiatry 2002; 159 (05) 873-874
• 35 Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 2011; 73 (02) 114-126
• 36 Yoshizawa K, Takeshima M, Ishino S. et al. Severity of depressive symptoms is associated with venous thromboembolism in hospitalized patients with a major depressive episode. Neuropsychiatr Dis Treat 2021; 17: 2955-2963
• 37 Freshman RD, Salesky M, Cogan CJ, Lansdown DA, Zhang AL. Association between comorbid depression and rates of postoperative complications, readmissions, and revision arthroscopic procedures after elective hip arthroscopy. Orthop J Sports Med 2021; 9 (09) 23 259671211036493
• 38 Browne JA, Sandberg BF, D'Apuzzo MR, Novicoff WM. Depression is associated with early postoperative outcomes following total joint arthroplasty: a nationwide database study. J Arthroplasty 2014; 29 (03) 481-483
• 39 Schulte LM, O'Brien JR, Bean MC, Pierce TP, Yu WD, Meals C. Deep vein thrombosis and pulmonary embolism after spine surgery: incidence and patient risk factors. Am J Orthop 2013; 42 (06) 267-270
• 40 Visseren FLJ, Mach F, Smulders YM. et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42 (34) 3227-3337
• 41 Kim Y, Lee YS, Kim MG. et al. The effect of selective serotonin reuptake inhibitors on major adverse cardiovascular events: a meta-analysis of randomized-controlled studies in depression. Int Clin Psychopharmacol 2019; 34 (01) 9-17
• 42 Mahdanian AA, Rej S, Bacon SL, Ozdin D, Lavoie KL, Looper K. Serotonergic antidepressants and perioperative bleeding risk: a systematic review. Expert Opin Drug Saf 2014; 13 (06) 695-704
• 43 Suvarna B, Suvarna A, Phillips R, Juster RP, McDermott B, Sarnyai Z. Health risk behaviours and allostatic load: a systematic review. Neurosci Biobehav Rev 2020; 108: 694-711
• 44 Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163 (19) 2368-2392
• 45 Almaghrabi TS, McDonald MM, Cai C. et al. Cocaine use is associated with more rapid clot formation and weaker clot strength in acute stroke patients. Int J Cerebrovasc Dis Stroke 2019; 2 (01) 110
• 46 Von Känel R, Vökt F, Biasiutti FD, Stauber S, Wuillemin WA, Lukas PS. Relation of psychological distress to the international normalized ratio in patients with venous thromboembolism with and without oral anticoagulant therapy. J Thromb Haemost 2012; 10 (08) 1547-1555
• 47 Hawk TL, Havrda DE. Effect of stress on international normalized ratio during warfarin therapy. Ann Pharmacother 2002; 36 (04) 617-620
• 48 Pan S, Allahwerdy F, Kim K. et al. Associations between anticoagulant treatment pathways and self-reported harms in patients recently diagnosed with venous thromboembolism. Thromb Res 2019; 182: 95-100
• 49 Perrin JM, MacLean Jr WE, Janco RL, Gortmaker SL. Stress and incidence of bleeding in children and adolescents with hemophilia. J Pediatr 1996; 128 (01) 82-88
• 50 Subramanian K, Pravallika M, Menon V. Evidence for stress-induced bleeding in a patient with von-Willebrand factor deficiency. Indian J Psychol Med 2018; 40 (03) 292-295
• 51 Jern C, Eriksson E, Tengborn L, Risberg B, Wadenvik H, Jern S. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 1989; 62 (02) 767-771
• 52 Hoirisch-Clapauch S. Anxiety-related bleeding and thrombosis. Semin Thromb Hemost 2018; 44 (07) 656-661
• 53 Fung EH, Lazar BS. Hypnosis as an adjunct in the treatment of von Willebrand's disease. Int J Clin Exp Hypn 1983; 31 (04) 256-265
• 54 Palareti L, Melotti G, Cassis F, Nevitt SJ, Iorio A. Psychological interventions for people with hemophilia. Cochrane Database Syst Rev 2020; 3 (03) CD010215
• 55 Forbes CD, Barr RD, Reid G. et al. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. BMJ 1972; 2 (5809): 311-313
• 56 Lin LL, Gu HY, Yao YY. et al. The association between watching football matches and the risk of cardiovascular events: a meta-analysis. J Sports Sci 2019; 37 (24) 2826-2834
• 57 Jacquet-Smailovic M, Brennstuhl MJ, Tarquinio CL, Tarquinio C. Relationship between cumulative adverse childhood experiences and myocardial infarction in adulthood: a systematic review and meta-analysis. J Child Adolesc Trauma 2021; 15 (03) 701-714
• 58 Manrique-Garcia E, Sidorchuk A, Hallqvist J, Moradi T. Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis. J Epidemiol Community Health 2011; 65 (04) 301-309
• 59 Kerr GD, Slavin H, Clark D, Coupar F, Langhorne P, Stott DJ. Do vascular risk factors explain the association between socioeconomic status and stroke incidence: a meta-analysis. Cerebrovasc Dis 2011; 31 (01) 57-63
• 60 Kivimäki M, Nyberg ST, Batty GD. et al; IPD-Work Consortium. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet 2012; 380 (9852): 1491-1497
• 61 Kivimäki M, Virtanen M, Elovainio M, Kouvonen A, Väänänen A, Vahtera J. Work stress in the etiology of coronary heart disease–a meta-analysis. Scand J Work Environ Health 2006; 32 (06) 431-442
• 62 Huang Y, Xu S, Hua J. et al. Association between job strain and risk of incident stroke: a meta-analysis. Neurology 2015; 85 (19) 1648-1654
• 63 Kivimäki M, Jokela M, Nyberg ST. et al; IPD-Work Consortium. Long working hours and risk of coronary heart disease and stroke: a systematic review and meta-analysis of published and unpublished data for 603,838 individuals. Lancet 2015; 386 (10005): 1739-1746
• 64 Heikkilä K, Pentti J, Madsen IEH. et al. Job strain as a risk factor for peripheral artery disease: a multi-cohort study. J Am Heart Assoc 2020; 9 (09) e013538
• 65 Richardson S, Shaffer JA, Falzon L, Krupka D, Davidson KW, Edmondson D. Meta-analysis of perceived stress and its association with incident coronary heart disease. Am J Cardiol 2012; 110 (12) 1711-1716
• 66 Booth J, Connelly L, Lawrence M. et al. Evidence of perceived psychosocial stress as a risk factor for stroke in adults: a meta-analysis. BMC Neurol 2015; 15: 233
• 67 Valtorta NK, Kanaan M, Gilbody S, Ronzi S, Hanratty B. Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies. Heart 2016; 102 (13) 1009-1016
• 68 Carey IM, Shah SM, DeWilde S, Harris T, Victor CR, Cook DG. Increased risk of acute cardiovascular events after partner bereavement: a matched cohort study. JAMA Intern Med 2014; 174 (04) 598-605
• 69 Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol 2009; 53 (11) 936-946
• 70 Chen H, Zhang B, Xue W. et al. Anger, hostility and risk of stroke: a meta-analysis of cohort studies. J Neurol 2019; 266 (04) 1016-1026
• 71 Gan Y, Gong Y, Tong X. et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371
• 72 Emdin CA, Odutayo A, Wong CX, Tran J, Hsiao AJ, Hunn BH. Meta-analysis of anxiety as a risk factor for cardiovascular disease. Am J Cardiol 2016; 118 (04) 511-519
• 73 Jacquet-Smailovic M, Brennsthul MJ, Denis I, Kirche A, Tarquinio C, Tarquinio C. Relationship between post-traumatic stress disorder and subsequent myocardial infarction: a systematic review and meta-analysis. J Affect Disord 2022; 297: 525-535
• 74 Nanavati HD, Arevalo A, Memon AA, Lin C. Associations between posttraumatic stress and stroke: a systematic review and meta-analysis. J Trauma Stress 2023; 36 (02) 259-271
• 75 Anand VV, Zhe ELC, Chin YH. et al. Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: a meta-analysis using multidimensional socioeconomic status indices. Int J Cardiol 2023; 383: 140-150
• 76 Lee MH, Li PY, Li B. et al. Lower socioeconomic status is associated with higher rates of critical limb ischemia presentation and post-revascularization amputation. J Vasc Surg 2022; 75 (03) 1121-1122
• 77 Li J, Zhang M, Loerbroks A, Angerer P, Siegrist J. Work stress and the risk of recurrent coronary heart disease events: a systematic review and meta-analysis. Int J Occup Med Environ Health 2015; 28 (01) 8-19
• 78 Barth J, Schneider S, von Känel R. Lack of social support in the etiology and the prognosis of coronary heart disease: a systematic review and meta-analysis. Psychosom Med 2010; 72 (03) 229-238
• 79 Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33 (03) 203-216
• 80 Shewangizaw S, Fekadu W, Gebregzihabhier Y, Mihretu A, Sackley C, Alem A. Impact of depression on stroke outcomes among stroke survivors: systematic review and meta-analysis. PLoS One 2023; 18 (12) e0294668
• 81 Scierka LE, Mena-Hurtado C, Ahmed ZV. et al. The association of depression with mortality and major adverse limb event outcomes in patients with peripheral artery disease: a systematic review and meta-analysis. J Affect Disord 2023; 320: 169-177
• 82 Li J, Ji F, Song J. et al. Anxiety and clinical outcomes of patients with acute coronary syndrome: a meta-analysis. BMJ Open 2020; 10 (07) e034135
• 83 Sahebi A, Nejati-Zarnaqi B, Vasei N, Jahangiri K. Deep vein thrombosis after earthquake: a systematic review and meta-analysis. Disaster Med Public Health Prep 2023; 17: e304
• 84 Holst AG, Jensen G, Prescott E. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121 (17) 1896-1903
• 85 Rosengren A, Fredén M, Hansson PO, Wilhelmsen L, Wedel H, Eriksson H. Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost 2008; 6 (04) 558-564
• 86 Kivimäki M, Nyberg ST, Batty GD, Madsen IEH, Tabák AG. IPD-Work Consortium. Long working hours and risk of venous thromboembolism. Epidemiology 2018; 29 (05) e42-e44
• 87 Kowal C, Peyre H, Amad A. et al. Psychotic, mood, and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis. Psychosom Med 2020; 82 (09) 838-849
• 88 Gradus JL, Farkas DK, Svensson E. et al. Associations between stress disorders and cardiovascular disease events in the Danish population. BMJ Open 2015; 5 (12) e009334
• 89 Sumner JA, Kubzansky LD, Kabrhel C. et al. Associations of trauma exposure and posttraumatic stress symptoms with venous thromboembolism over 22 years in women. J Am Heart Assoc 2016; 5 (05) e003197
• 90 von Känel R, Margani A, Stauber S. et al. Depressive symptoms as a novel risk factor for recurrent venous thromboembolism: a longitudinal observational study in patients referred for thrombophilia investigation. PLoS One 2015; 10 (05) e0125858
• 91 Rozanski A. Behavioral cardiology: current advances and future directions. J Am Coll Cardiol 2014; 64 (01) 100-110
• 92 Adelborg K, Sundbøll J, Videbech P, Grove EL. The risk of thromboembolism in users of antidepressants and antipsychotics. Adv Exp Med Biol 2017; 906: 351-361
• 93 Alqdwah-Fattouh R, Rodríguez-Martín S, de Abajo FJ. et al. Differential effects of antidepressant subgroups on risk of acute myocardial infarction: a nested case-control study. Br J Clin Pharmacol 2020; 86 (10) 2040-2050
• 94 Kunutsor SK, Seidu S, Khunti K. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Ann Med 2018; 50 (06) 529-537
• 95 Lippi G, Montagnana M, Favaloro EJ, Franchini M. Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 2009; 35 (03) 325-336
• 96 Jørgensen H, Horváth-Puhó E, Laugesen K, Brækkan SK, Hansen JB, Sørensen HT. Venous thromboembolism and risk of depression: a population-based cohort study. J Thromb Haemost 2023; 21 (04) 953-962
• 97 Kämpf S, Weißbach L, Zotz R. Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event. Blood Coagul Fibrinolysis 2022; 33 (05) 257-260
• 98 Bjerkeset O, Nordahl HM, Mykletun A, Holmen J, Dahl AA. Anxiety and depression following myocardial infarction: gender differences in a 5-year prospective study. J Psychosom Res 2005; 58 (02) 153-161
• 99 Fischer S, Meisinger C, Linseisen J, Berghaus TM, Kirchberger I. Depression and anxiety up to two years after acute pulmonary embolism: prevalence and predictors. Thromb Res 2023; 222: 68-74
• 100 Gkena N, Kirgou P, Gourgoulianis KI, Malli F. Mental health and quality of life in pulmonary embolism: a literature review. Adv Respir Med 2023; 91 (02) 174-184
• 101 Edmondson D, von Känel R. Post-traumatic stress disorder and cardiovascular disease. Lancet Psychiatry 2017; 4 (04) 320-329
• 102 Abbas CC, Schmid JP, Guler E. et al. Trajectory of posttraumatic stress disorder caused by myocardial infarction: a two-year follow-up study. Int J Psychiatry Med 2009; 39 (04) 359-376
• 103 Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review. PLoS One 2012; 7 (06) e38915
• 104 Tosetto A. Association or causation: the Janus face of observational research. J Thromb Haemost 2008; 6 (04) 555-557
• 105 de Geus EJC. Mendelian randomization supports a causal effect of depression on cardiovascular disease as the main source of their comorbidity. J Am Heart Assoc 2021; 10 (01) e019861
• 106 Polimanti R, Wendt FR, Pathak GA. et al. Understanding the comorbidity between posttraumatic stress severity and coronary artery disease using genome-wide information and electronic health records. Mol Psychiatry 2022; 27 (10) 3961-3969
• 107 Chen M, Wang Z, Xu H, Li W, Teng P, Ma L. Genetics of mood instability and risk of cardiovascular diseases: a univariable and multivariable Mendelian randomization study. J Affect Disord 2024; 347: 406-413
• 108 Steptoe A, Strike PC, Perkins-Porras L, McEwan JR, Whitehead DL. Acute depressed mood as a trigger of acute coronary syndromes. Biol Psychiatry 2006; 60 (08) 837-842
• 109 Hu M, Yang T, Yang Y. Causal associations of education level with cardiovascular diseases, cardiovascular biomarkers, and socioeconomic factors. Am J Cardiol 2024; 213: 76-85
• 110 Ward J, Le NQ, Suryakant S. et al. Polygenic risk of major depressive disorder as a risk factor for venous thromboembolism. Blood Adv 2023; 7 (18) 5341-5350
• 111 Danesh J, Lewington S, Thompson SG. et al; Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005; 294 (14) 1799-1809
• 112 Willeit P, Thompson A, Aspelund T. et al. Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses. PLoS One 2013; 8 (02) e55175
• 113 Sonneveld MA, de Maat MP, Leebeek FW. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis. Blood Rev 2014; 28 (04) 167-178
• 114 Jung RG, Motazedian P, Ramirez FD. et al. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis. Thromb J 2018; 16: 12
• 115 Kremers B, Wübbeke L, Mees B, Ten Cate H, Spronk H, Ten Cate-Hoek A. Plasma biomarkers to predict cardiovascular outcome in patients with peripheral artery disease: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2020; 40 (09) 2018-2032
• 116 Chu SG, Becker RC, Berger PB. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost 2010; 8 (01) 148-156
• 117 Wisman PP, Roest M, Asselbergs FW. et al. Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis. J Thromb Haemost 2014; 12 (05) 736-747
• 118 Crescente M, Di Castelnuovo A, Iacoviello L, de Gaetano G, Cerletti C. PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a meta-analysis of 19 studies comprising 3,003 patients. Thromb Haemost 2008; 99 (06) 1129-1131
• 119 Lowe G, Wu O, van Hylckama Vlieg A, Folsom A, Rosendaal F, Woodward M. Plasma levels of coagulation factors VIII and IX and risk of venous thromboembolism: systematic review and meta-analysis. Thromb Res 2023; 229: 31-39
• 120 Di Minno MND, Calcaterra I, Papa A. et al. Diagnostic accuracy of D-Dimer testing for recurrent venous thromboembolism: a systematic review with meta-analysis: VTE recurrence and D-dimer. Eur J Intern Med 2021; 89: 39-47
• 121 Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011; 9 (02) 120-138
• 122 Rietveld IM, Lijfering WM, le Cessie S. et al. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. J Thromb Haemost 2019; 17 (01) 99-109
• 123 Zhao JV, Schooling CM. Coagulation factors and the risk of ischemic heart disease: a Mendelian randomization study. Circ Genom Precis Med 2018; 11 (01) e001956
• 124 Verdier H, Thomas P, Batista J. et al. A signature of platelet reactivity in CBC scattergrams reveals genetic predictors of thrombotic disease risk. Blood 2023; 142 (22) 1895-1908
• 125 Ward-Caviness CK, de Vries PS, Wiggins KL. et al. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease. PLoS One 2019; 14 (05) e0216222
• 126 Sabater-Lleal M, Huffman JE, de Vries PS. et al; INVENT Consortium; MEGASTROKE Consortium of the International Stroke Genetics Consortium (ISGC). Genome-wide association transethnic meta-analyses identifies novel associations regulating coagulation factor VIII and von Willebrand factor plasma levels. Circulation 2019; 139 (05) 620-635
• 127 Song C, Burgess S, Eicher JD, O'Donnell CJ, Johnson AD. Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease. J Am Heart Assoc 2017; 6 (06) e004918
• 128 Yuan S, Burgess S, Laffan M. et al. Genetically proxied inhibition of coagulation factors and risk of cardiovascular disease: a Mendelian randomization study. J Am Heart Assoc 2021; 10 (08) e019644
• 129 de Vries PS, Sabater-Lleal M, Huffman JE. et al; INVENT Consortium, MEGASTROKE Consortium of the International Stroke Genetics Consortium. A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology. Blood 2019; 133 (09) 967-977
• 130 Small AM, Huffman JE, Klarin D. et al; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Hemostasis Working Group and the VA Million Veteran Program. Mendelian randomization analysis of hemostatic factors and their contribution to peripheral artery disease-brief report. Arterioscler Thromb Vasc Biol 2021; 41 (01) 380-386
• 131 Yuan S, Titova OE, Zhang K. et al. Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses. Br J Haematol 2023; 201 (04) 783-792
• 132 Sanderson E. Multivariable Mendelian randomization and mediation. Cold Spring Harb Perspect Med 2021; 11 (02) a038984
• 133 Yin H, Cheng X, Liang Y. et al. High perceived stress may shorten activated partial thromboplastin time and lead to worse clinical outcomes in patients with coronary heart disease. Front Cardiovasc Med 2021; 8: 769857
• 134 László KD, Ahnve S, Hallqvist J, Ahlbom A, Janszky I. Job strain predicts recurrent events after a first acute myocardial infarction: the Stockholm Heart Epidemiology Program. J Intern Med 2010; 267 (06) 599-611
• 135 Rafanelli C, Gostoli S, Buzzichelli S. et al. Sequential combination of cognitive-behavioral treatment and well-being therapy in depressed patients with acute coronary syndromes: a randomized controlled trial (TREATED-ACS study). Psychother Psychosom 2020; 89 (06) 345-356
• 136 Mohammadi N, Aghayousefi A, Nikrahan GR. et al. The impact of an optimism training intervention on biological measures associated with cardiovascular health: data from a randomized controlled trial. Psychosom Med 2020; 82 (07) 634-640
• 137 von Känel R, Mills PJ, Dimsdale JE. et al. Effects of psychosocial interventions and caregiving stress on cardiovascular biomarkers in family dementia caregivers: the UCSD Pleasant Events Program (PEP) randomized controlled trial. J Gerontol A Biol Sci Med Sci 2020; 75 (11) 2215-2223
• 138 Deter HC, Orth-Gomér K, Rauch-Kröhnert U. et al; SPIRR-CAD - Study Group. Depression, anxiety, and vital exhaustion are associated with pro-coagulant markers in depressed patients with coronary artery disease - a cross sectional and prospective secondary analysis of the SPIRR-CAD trial. J Psychosom Res 2021; 151: 110659
• 139 Claesson M, Birgander LS, Jansson JH. et al. Cognitive-behavioural stress management does not improve biological cardiovascular risk indicators in women with ischaemic heart disease: a randomized-controlled trial. J Intern Med 2006; 260 (04) 320-331
• 140 Jiang W, Boyle SH, Ortel TL. et al. Platelet aggregation and mental stress induced myocardial ischemia: results from the Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT) study. Am Heart J 2015; 169 (04) 496-507.e1
• 141 Canevari A, Tacconi F, Zucchella M, Pacchiarini L, Soffiantino F, Grignani G. Antithrombin III biological activity and emotional stress in patients with coronary artery disease. Haematologica 1992; 77 (02) 180-182
• 142 von Känel R, Hamer M, Malan NT, Scheepers K, Meiring M, Malan L. Procoagulant reactivity to laboratory acute mental stress in Africans and Caucasians, and its relation to depressive symptoms: the SABPA study. Thromb Haemost 2013; 110 (05) 977-986
• 143 Hamer M, Gibson EL, Vuononvirta R, Williams E, Steptoe A. Inflammatory and hemostatic responses to repeated mental stress: individual stability and habituation over time. Brain Behav Immun 2006; 20 (05) 456-459
• 144 von Känel R, Preckel D, Zgraggen L. et al. The effect of natural habituation on coagulation responses to acute mental stress and recovery in men. Thromb Haemost 2004; 92 (06) 1327-1335
• 145 Loupos D, Tsalis G, Alexiou S, Gounaris I. Changes of plasma fibrinogen and fibrinolysis in response to competition stress in swimming coaches. J Sports Med Phys Fitness 2005; 45 (03) 424-427
• 146 Kim SC, Lee HJ, Shin DM. et al. Cardiovascular risk in fire academy instructors during live-fire simulation activity. Ann Burns Fire Disasters 2018; 31 (04) 313-321
• 147 Arble E, Daugherty AM, Arnetz B. Differential effects of physiological arousal following acute stress on police officer performance in a simulated critical incident. Front Psychol 2019; 10: 759
• 148 Smith DL, Horn GP, Petruzzello SJ. et al. Effect of obesity on acute hemostatic responses to live-fire training drills. Am J Cardiol 2014; 114 (11) 1768-1771
• 149 Biondi G, Farrace S, Mameli G, Marongiu F. Is there a hypercoagulable state in military fighter pilots?. Aviat Space Environ Med 1996; 67 (06) 568-571
• 150 Kawano TA, Aoki N, Homori M. et al. Mental stress and physical exercise increase platelet-dependent thrombin generation. Heart Vessels 2000; 15 (06) 280-288
• 151 Kario K, Matsuo T, Kobayashi H, Yamamoto K, Shimada K. Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: possible triggering of cardiovascular events after a major earthquake. J Am Coll Cardiol 1997; 29 (05) 926-933
• 152 Watanabe H, Kodama M, Tanabe N. et al. Impact of earthquakes on risk for pulmonary embolism. Int J Cardiol 2008; 129 (01) 152-154
• 153 Venema CL, Schutgens REG, Fischer K. Pathophysiological mechanisms of endogenous FVIII release following strenuous exercise in non-severe haemophilia: a review. Thromb Haemost 2017; 117 (12) 2237-2242
• 154 Strike PC, Magid K, Brydon L, Edwards S, McEwan JR, Steptoe A. Exaggerated platelet and hemodynamic reactivity to mental stress in men with coronary artery disease. Psychosom Med 2004; 66 (04) 492-500
• 155 Wirtz PH, Redwine LS, Baertschi C, Spillmann M, Ehlert U, von Känel R. Coagulation activity before and after acute psychosocial stress increases with age. Psychosom Med 2008; 70 (04) 476-481
• 156 Jern C, Manhem K, Eriksson E, Tengborn L, Risberg B, Jern S. Hemostatic responses to mental stress during the menstrual cycle. Thromb Haemost 1991; 66 (05) 614-618
• 157 von Känel R, Mills PJ, Ziegler MG, Dimsdale JE. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002; 144 (01) 68-72
• 158 von Känel R, Dimsdale JE, Ziegler MG. et al. Effect of acute psychological stress on the hypercoagulable state in subjects (spousal caregivers of patients with Alzheimer's disease) with coronary or cerebrovascular disease and/or systemic hypertension. Am J Cardiol 2001; 87 (12) 1405-1408
• 159 von Känel R, Dimsdale JE, Adler KA, Patterson TL, Mills PJ, Grant I. Effects of depressive symptoms and anxiety on hemostatic responses to acute mental stress and recovery in the elderly. Psychiatry Res 2004; 126 (03) 253-264
• 160 Wirtz PH, Ehlert U, Emini L. et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med 2006; 68 (06) 851-858
• 161 Austin AW, Wirtz PH, Patterson SM, Stutz M, von Känel R. Stress-induced alterations in coagulation: assessment of a new hemoconcentration correction technique. Psychosom Med 2012; 74 (03) 288-295
• 162 van Diemen JJK, van Dijk A, Racca C. et al. The viewing of a 'Bloodcurdling' horror movie increases platelet reactivity: a randomized cross-over study in healthy volunteers. Thromb Res 2019; 182: 27-32
• 163 Nemeth B, Scheres LJ, Lijfering WM, Rosendaal FR. Bloodcurdling movies and measures of coagulation: fear factor crossover trial. BMJ 2015; 351: h6367
• 164 Lazzarino AI, Hamer M, Gaze D. et al. The association between fibrinogen reactivity to mental stress and high-sensitivity cardiac troponin T in healthy adults. Psychoneuroendocrinology 2015; 59: 37-48
• 165 Brydon L, Steptoe A. Stress-induced increases in interleukin-6 and fibrinogen predict ambulatory blood pressure at 3-year follow-up. J Hypertens 2005; 23 (05) 1001-1007
• 166 Steptoe A, Kivimäki M, Lowe G, Rumley A, Hamer M. Blood pressure and fibrinogen responses to mental stress as predictors of incident hypertension over an 8-year period. Ann Behav Med 2016; 50 (06) 898-906
• 167 Kaptoge S, White IR, Thompson SG. et al; Fibrinogen Studies Collaboration. Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies: the fibrinogen studies collaboration. Am J Epidemiol 2007; 166 (08) 867-879
• 168 Hansen AM, Larsen AD, Rugulies R, Garde AH, Knudsen LE. A review of the effect of the psychosocial working environment on physiological changes in blood and urine. Basic Clin Pharmacol Toxicol 2009; 105 (02) 73-83
• 169 Chen Z, Wang J, Carru C, Sedda S, Nivoli AM, Li Z. Meta-analysis of peripheral mean platelet volume in patients with mental disorders: comparisons in depression, anxiety, bipolar disorder, and schizophrenia. Brain Behav 2023; 13 (11) e3240
• 170 Wium-Andersen MK, Orsted DD, Nordestgaard BG. Association between elevated plasma fibrinogen and psychological distress, and depression in 73,367 individuals from the general population. Mol Psychiatry 2013; 18 (08) 854-855
• 171 Stewart JC, Polanka BM, So-Armah KA. et al. Associations of total, cognitive/affective, and somatic depressive symptoms and antidepressant use with cardiovascular disease-relevant biomarkers in HIV: Veterans Aging Cohort Study. Psychosom Med 2020; 82 (05) 461-470
• 172 Hussain MA, Watson CW, Morgan EE. et al. Combined effects of loneliness and inflammation on depression in people with HIV. J Neurovirol 2023; 29 (05) 538-554
• 173 Jiang H, Li X, Chen S. et al. Plasminogen activator inhibitor-1 in depression: results from animal and clinical studies. Sci Rep 2016; 6: 30464
• 174 von Känel R, Merz F, Pfister H. et al. Evidence for an enhanced procoagulant state in remitted major depression. World J Biol Psychiatry 2020; 21 (10) 766-774
• 175 Koudouovoh-Tripp P, Hüfner K, Egeter J. et al. Stress enhances proinflammatory platelet activity: the impact of acute and chronic mental stress. J Neuroimmune Pharmacol 2021; 16 (02) 500-512
• 176 Jain S, Mills PJ, von Känel R, Hong S, Dimsdale JE. Effects of perceived stress and uplifts on inflammation and coagulability. Psychophysiology 2007; 44 (01) 154-160
• 177 Wenneberg SR, Schneider RH, Walton KG. et al. Anger expression correlates with platelet aggregation. Behav Med 1997; 22 (04) 174-177
• 178 Markovitz JH. Hostility is associated with increased platelet activation in coronary heart disease. Psychosom Med 1998; 60 (05) 586-591
• 179 Serebruany VL, Glassman AH, Malinin AI. et al. Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials. Blood Coagul Fibrinolysis 2003; 14 (06) 563-567
• 180 Lukas PS, Neugebauer A, Schnyder S. et al. Depressive symptoms, perceived social support, and prothrombotic measures in patients with venous thromboembolism. Thromb Res 2012; 130 (03) 374-380
• 181 Mausbach BT, von Känel R, Aschbacher K. et al. Spousal caregivers of patients with Alzheimer's disease show longitudinal increases in plasma level of tissue-type plasminogen activator antigen. Psychosom Med 2007; 69 (08) 816-822
• 182 Mausbach BT, Aschbacher K, Patterson TL. et al. Effects of placement and bereavement on psychological well-being and cardiovascular risk in Alzheimer's caregivers: a longitudinal analysis. J Psychosom Res 2007; 62 (04) 439-445
• 183 Matthews KA, Schott LL, Bromberger J, Cyranowski J, Everson-Rose SA, Sowers MF. Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition. Psychosom Med 2007; 69 (02) 124-130
• 184 Von Känel R, Bellingrath S, Kudielka BM. Association between longitudinal changes in depressive symptoms and plasma fibrinogen levels in school teachers. Psychophysiology 2009; 46 (03) 473-480
• 185 von Känel R, Pazhenkottil AP, Meister-Langraf RE. et al. Longitudinal association between cognitive depressive symptoms and D-dimer levels in patients following acute myocardial infarction. Clin Cardiol 2021; 44 (09) 1316-1325
• 186 Martins-de-Souza D, Maccarrone G, Ising M. et al. Plasma fibrinogen: now also an antidepressant response marker?. Transl Psychiatry 2014; 4 (01) e352
• 187 Parmer RJ, Gong Y, Yoo SH, Miles LA. Neuroendocrine targeting of tissue plasminogen activator (t-PA). J Neurol Disord Stroke 2020; 7 (01) 1153
• 188 Agorastos A, Chrousos GP. The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Mol Psychiatry 2022; 27 (01) 502-513
• 189 Russell G, Lightman S. The human stress response. Nat Rev Endocrinol 2019; 15 (09) 525-534
• 190 von Känel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65 (06) 357-369
• 191 Venugopal B, Sharon R, Abramovitz R, Khasin A, Miskin R. Plasminogen activator inhibitor-1 in cardiovascular cells: rapid induction after injecting mice with kainate or adrenergic agents. Cardiovasc Res 2001; 49 (02) 476-483
• 192 Isingrini E, Belzung C, d'Audiffret A, Camus V. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging. Am J Geriatr Psychiatry 2011; 19 (04) 335-346
• 193 Yamamoto K, Takeshita K, Shimokawa T. et al. Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals. Proc Natl Acad Sci U S A 2002; 99 (02) 890-895
• 194 Stämpfli SF, Camici GG, Keller S. et al. Restraint stress enhances arterial thrombosis in vivo–role of the sympathetic nervous system. Stress 2014; 17 (01) 126-132
• 195 Bao LL, Jiang WQ, Sun FJ. et al. The influence of psychological stress on arginine vasopressin concentration in the human plasma and cerebrospinal fluid. Neuropeptides 2014; 48 (06) 361-369
• 196 Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost 2003; 1 (04) 682-689
• 197 Mannucci PM. Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood 1997; 90 (07) 2515-2521
• 198 Filep J, Rosenkranz B. Mechanism of vasopressin-induced platelet aggregation. Thromb Res 1987; 45 (01) 7-15
• 199 Gatica S, Aravena D, Echeverría C, Santibanez JF, Riedel CA, Simon F. Effects of adrenergic receptor stimulation on human hemostasis: a systematic review. Adv Exp Med Biol 2023; 1408: 49-63
• 200 Ali-Saleh M, Sarig G, Ablin JN, Brenner B, Jacob G. Inhalation of a short-acting β2-adrenoreceptor agonist induces a hypercoagulable state in healthy subjects. PLoS One 2016; 11 (07) e0158652
• 201 von Känel R, Heimgartner N, Stutz M. et al. Prothrombotic response to norepinephrine infusion, mimicking norepinephrine stress-reactivity effects, is partly mediated by α-adrenergic mechanisms. Psychoneuroendocrinology 2019; 105: 44-50
• 202 Nordły A, Gjesdal K, Jaeger S, Berntsen H. The effect of noradrenalin infusion on plasma and platelet lipids and platelet function in man. Thromb Diath Haemorrh 1975; 33 (02) 328-334
• 203 Austin AW, Patterson SM, von Känel R. Hemoconcentration and hemostasis during acute stress: interacting and independent effects. Ann Behav Med 2011; 42 (02) 153-173
• 204 von Känel R, Kudielka BM, Haeberli A, Stutz M, Fischer JE, Patterson SM. Prothrombotic changes with acute psychological stress: combined effect of hemoconcentration and genuine coagulation activation. Thromb Res 2009; 123 (04) 622-630
• 205 Muldoon MF. Challenges in controlling for the effects of hematoconcentration. Psychosom Med 2013; 75 (02) 223
• 206 Zgraggen L, Fischer JE, Mischler K, Preckel D, Kudielka BM, von Känel R. Relationship between hemoconcentration and blood coagulation responses to acute mental stress. Thromb Res 2005; 115 (03) 175-183
• 207 Engan H, Schagatay E. “Spleen contraction and hemoconcentration” regarding the review “hemoconcentration and hemostasis during acute stress: interacting and independent effects” by Austin et al. 2011. Ann Behav Med 2015; 49 (04) 634-635
• 208 Patterson SM, Krantz DS, Gottdiener JS, Hecht G, Vargot S, Goldstein DS. Prothrombotic effects of environmental stress: changes in platelet function, hematocrit, and total plasma protein. Psychosom Med 1995; 57 (06) 592-599
• 209 Wallén NH, Goodall AH, Li N, Hjemdahl P. Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 1999; 97 (01) 27-35
• 210 Tanaka KA, Terada R, Butt AL, Mazzeffi MA, McNeil JS. Factor VIII: a dynamic modulator of hemostasis and thrombosis in trauma. Anesth Analg 2023; 136 (05) 894-904
• 211 Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005; 3 (08) 1800-1814
• 212 Klavina PA, Leon G, Curtis AM, Preston RJS. Dysregulated haemostasis in thrombo-inflammatory disease. Clin Sci (Lond) 2022; 136 (24) 1809-1829
• 213 Verhoef JJ, Barendrecht AD, Nickel KF. et al. Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Blood 2017; 129 (12) 1707-1717
• 214 Weitz JI, Fredenburgh JC. Platelet polyphosphate: the long and the short of it. Blood 2017; 129 (12) 1574-1575
• 215 Mischler K, Fischer JE, Zgraggen L, Kudielka BM, Preckel D, von Känel R. The effect of repeated acute mental stress on habituation and recovery responses in hemoconcentration and blood cells in healthy men. Life Sci 2005; 77 (10) 1166-1179
• 216 Gramotnev DK, Gramotnev G. Psychological stress and psychosomatic treatment: major impact on serious blood disorders?. Neuroimmunomodulation 2011; 18 (03) 171-183
• 217 Frimerman A, Miller HI, Laniado S, Keren G. Changes in hemostatic function at times of cyclic variation in occupational stress. Am J Cardiol 1997; 79 (01) 72-75
• 218 Chen S, Du C, Shen M. et al. Sympathetic stimulation facilitates thrombopoiesis by promoting megakaryocyte adhesion, migration, and proplatelet formation. Blood 2016; 127 (08) 1024-1035
• 219 Vidović A, Grubišić-Ilić M, Kozarić-Kovačić D. et al. Exaggerated platelet reactivity to physiological agonists in war veterans with posttraumatic stress disorder. Psychoneuroendocrinology 2011; 36 (02) 161-172
• 220 Dietrich-Muszalska A, Wachowicz B. Platelet haemostatic function in psychiatric disorders: effects of antidepressants and antipsychotic drugs. World J Biol Psychiatry 2017; 18 (08) 564-574
• 221 Hüfner K, Kandler C, Koudouovoh-Tripp P. et al. Bioprofiling of platelets in medicated patients with depression. J Affect Disord 2015; 172: 81-88
• 222 von Känel R, Kudielka BM, Helfricht S. et al. Effects of aspirin and propranolol on the acute psychological stress response in factor VIII coagulant activity: a randomized, double-blind, placebo-controlled experimental study. Blood Coagul Fibrinolysis 2008; 19 (01) 75-81
• 223 Hoppener MR, Kraaijenhagen RA, Hutten BA, Büller HR, Peters RJ, Levi M. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis. J Thromb Haemost 2004; 2 (08) 1316-1320
• 224 von Känel R, Bacon SL. Hemostasis and endothelial function. In: Waldstein SR, Kop WJ, Suarez EC, Lovallo WR, Katzel LI. eds. Cardiovascular Behavioral Medicine. New York: Springer; 2022: 861-890
• 225 Konkle BA, Schuster SJ, Kelly MD. et al. Plasminogen activator inhibitor-1 messenger RNA expression is induced in rat hepatocytes in vivo by dexamethasone. Blood 1992; 79 (10) 2636-2642
• 226 von Känel R, Kudielka BM, Abd-el-Razik A, Gander ML, Frey K, Fischer JE. Relationship between overnight neuroendocrine activity and morning haemostasis in working men. Clin Sci (Lond) 2004; 107 (01) 89-95
• 227 von Känel R, Mausbach BT, Kudielka BM, Orth-Gomér K. Relation of morning serum cortisol to prothrombotic activity in women with stable coronary artery disease. J Thromb Thrombolysis 2008; 25 (02) 165-172
• 228 Lippi G, Franchini M, Salvagno GL, Montagnana M, Guidi GC. Higher morning serum cortisol level predicts increased fibrinogen but not shortened APTT. J Thromb Thrombolysis 2008; 26 (02) 103-105
• 229 van der Pas R, de Bruin C, Leebeek FW. et al. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. J Clin Endocrinol Metab 2012; 97 (04) 1303-1310
• 230 St-Jean M, Lim DST, Langlois F. Hypercoagulability in Cushing's syndrome: from arterial to venous disease. Best Pract Res Clin Endocrinol Metab 2021; 35 (02) 101496
• 231 Brotman DJ, Girod JP, Posch A. et al. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 2006; 118 (02) 247-252
• 232 Johannesdottir SA, Horváth-Puhó E, Dekkers OM. et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 2013; 173 (09) 743-752
• 233 Degroote C, von Känel R, Thomas L. et al. Lower diurnal HPA-axis activity in male hypertensive and coronary heart disease patients predicts future CHD risk. Front Endocrinol (Lausanne) 2023; 14: 1080938
• 234 von Känel R, Nelesen RA, Ziegler MG, Mausbach BT, Mills PJ, Dimsdale JE. Relation of autonomic activity to plasminogen activator inhibitor-1 plasma concentration and the role of body mass index. Blood Coagul Fibrinolysis 2007; 18 (04) 353-359
• 235 von Känel R, Thayer JF, Fischer JE. Nighttime vagal cardiac control and plasma fibrinogen levels in a population of working men and women. Ann Noninvasive Electrocardiol 2009; 14 (02) 176-184
• 236 von Känel R, Orth-Gomér K. Autonomic function and prothrombotic activity in women after an acute coronary event. J Womens Health (Larchmt) 2008; 17 (08) 1331-1337
• 237 Levi M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109 (22) 2698-2704
• 238 Vazquez-Garza E, Jerjes-Sanchez C, Navarrete A, Joya-Harrison J, Rodriguez D. Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians. J Thromb Thrombolysis 2017; 44 (03) 377-385
• 239 Matsuo T, Suzuki S, Kario K. Is it sufficient for hemostatic abnormalities alone to explain atherosclerotic change in coronary arteries?. Thromb Res 1999; 94 (02) 135-136
• 240 Marsland AL, Walsh C, Lockwood K, John-Henderson NA. The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis. Brain Behav Immun 2017; 64: 208-219
• 241 von Känel R, Kudielka BM, Hanebuth D, Preckel D, Fischer JE. Different contribution of interleukin-6 and cortisol activity to total plasma fibrin concentration and to acute mental stress-induced fibrin formation. Clin Sci (Lond) 2005; 109 (01) 61-67
• 242 Chrusciel P, Goch A, Banach M, Mikhailidis DP, Rysz J, Goch JH. Circadian changes in the hemostatic system in healthy men and patients with cardiovascular diseases. Med Sci Monit 2009; 15 (10) RA203-RA208
• 243 Chen Z, Zhang SL. The role of flavonoids in the prevention and management of cardiovascular complications: a narrative review. Ann Palliat Med 2021; 10 (07) 8254-8263
• 244 von Känel R, Meister RE, Stutz M. et al. Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy men. Thromb Haemost 2014; 112 (06) 1151-1158
• 245 Wirtz PH, von Känel R. Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep 2017; 19 (11) 111
• 246 Williams DP, Koenig J, Carnevali L. et al. Heart rate variability and inflammation: a meta-analysis of human studies. Brain Behav Immun 2019; 80: 219-226
• 247 von Känel R, Nelesen RA, Mills PJ, Ziegler MG, Dimsdale JE. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun 2008; 22 (04) 461-468
• 248 Lippi G, Franchini M, Favaloro EJ. Unsuspected triggers of venous thromboembolism–trivial or not so trivial?. Semin Thromb Hemost 2009; 35 (07) 597-604
• 249 Kajantie E, Phillips DI. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006; 31 (02) 151-178
• 250 Haider A, Bengs S, Luu J. et al. Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J 2020; 41 (13) 1328-1336
• 251 Steptoe A, Kunz-Ebrecht S, Rumley A, Lowe GD. Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women. Thromb Haemost 2003; 89 (01) 83-90
• 252 Wirtz PH, Redwine LS, Ehlert U, von Känel R. Independent association between lower level of social support and higher coagulation activity before and after acute psychosocial stress. Psychosom Med 2009; 71 (01) 30-37
• 253 Hamer M, Williams E, Vuonovirta R, Giacobazzi P, Gibson EL, Steptoe A. The effects of effort-reward imbalance on inflammatory and cardiovascular responses to mental stress. Psychosom Med 2006; 68 (03) 408-413
• 254 Aschbacher K, Mills PJ, von Känel R. et al. Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 2008; 22 (04) 493-502
• 255 Aschbacher K, Roepke SK, von Känel R. et al. Persistent versus transient depressive symptoms in relation to platelet hyperactivation: a longitudinal analysis of dementia caregivers. J Affect Disord 2009; 116 (1-2): 80-87
• 256 von Känel R, Bellingrath S, Kudielka BM. Association of vital exhaustion and depressive symptoms with changes in fibrin D-dimer to acute psychosocial stress. J Psychosom Res 2009; 67 (01) 93-101
• 257 Aschbacher K, Patterson TL, von Känel R. et al. Coping processes and hemostatic reactivity to acute stress in dementia caregivers. Psychosom Med 2005; 67 (06) 964-971
• 258 von Känel R, Merz F, Pfister H. et al. Acute stress-induced coagulation activation in patients with remitted major depression versus healthy controls and the role of stress-specific coping. Ann Behav Med 2020; 54 (08) 611-618
• 259 von Känel R, Abbas CC, Begré S, Saner H, Gander ML, Schmid JP. Posttraumatic stress disorder and soluble cellular adhesion molecules at rest and in response to a trauma-specific interview in patients after myocardial infarction. Psychiatry Res 2010; 179 (03) 312-317
• 260 von Känel R, Abbas CC, Schmid JP. et al. Momentary stress moderates procoagulant reactivity to a trauma-specific interview in patients with posttraumatic stress disorder caused by myocardial infarction. J Psychiatr Res 2010; 44 (14) 956-963
• 261 Cooksey AM, Momen N, Stocker R, Burgess SC. Identifying blood biomarkers and physiological processes that distinguish humans with superior performance under psychological stress. PLoS One 2009; 4 (12) e8371
• 262 Markovitz JH, Matthews KA, Kiss J, Smitherman TC. Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls. Psychosom Med 1996; 58 (02) 143-149
• 263 Wallén NH, Held C, Rehnqvist N, Hjemdahl P. Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. Eur Heart J 1997; 18 (05) 807-815
• 264 Samad Z, Boyle S, Ersboll M. et al; REMIT Investigators. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. J Am Coll Cardiol 2014; 64 (16) 1669-1678
• 265 Strike PC, Magid K, Whitehead DL, Brydon L, Bhattacharyya MR, Steptoe A. Pathophysiological processes underlying emotional triggering of acute cardiac events. Proc Natl Acad Sci U S A 2006; 103 (11) 4322-4327
• 266 Plourde A, Lavoie KL, Ouellet K, Carroll D, Ring C, Bacon SL. Hemodynamic, hemostatic, and endothelial reactions to acute psychological stress in depressed patients following coronary angiography. Psychophysiology 2013; 50 (08) 790-798
• 267 Walther LM, Wirtz PH. Physiological reactivity to acute mental stress in essential hypertension-a systematic review. Front Cardiovasc Med 2023; 10: 1215710
• 268 Palermo A, Bertalero P, Pizza N, Amelotti R, Libretti A. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients. J Hypertens Suppl 1989; 7 (06) S162-S163
• 269 Tomoda F, Takata M, Kagitani S. et al. Different platelet aggregability during mental stress in two stages of essential hypertension. Am J Hypertens 1999; 12 (11 Pt 1): 1063-1070
• 270 Wirtz PH, Ehlert U, Emini L, Rüdisüli K, Groessbauer S, von Känel R. Procoagulant stress reactivity and recovery in apparently healthy men with systolic and diastolic hypertension. J Psychosom Res 2007; 63 (01) 51-58
• 271 Steptoe A, Marmot M. Psychosocial, hemostatic, and inflammatory correlates of delayed poststress blood pressure recovery. Psychosom Med 2006; 68 (04) 531-537